Pediatric Cardiology, University of Minnesota/Masonic Children's Hospital, MN 55454, USA.
Clinical Sciences, Lunds University, Lund, Sweden.
Future Cardiol. 2021 Sep;17(6):1116-1122. doi: 10.2217/fca-2020-0169. Epub 2021 Jan 19.
In the pediatric population, conventional transvenous and epicardial pacemaker systems carry complications such as lead distortion due to growth/activity, in addition to other lead/pocket complications. A retrospective review of pediatric leadless pacing at the University of Minnesota Masonic Children's Hospital from 2018 to 2020 was performed. Rationale for pacing, demographics of patients, thresholds and longevity of devices were recorded. Seven leadless pacemaker insertions and one removal were performed successfully, in patients weighing between 19 kg and 58 kg. Three patients had Micra implantation via internal jugular vein. One pericardial effusion occurred perioperatively in a 19 kg patient with baseline thrombocytopenia, sideroblastic anemia and Pearson Marrow Pancreas syndrome. Leadless pacemaker implantation/early retrieval is feasible in pediatric patients.
在儿科人群中，传统的经静脉和心外膜起搏器系统会出现并发症，例如由于生长/活动导致的导线扭曲，以及其他导线/囊袋并发症。对明尼苏达梅奥医学院儿童医院 2018 年至 2020 年的小儿无导线起搏进行了回顾性研究。记录了起搏的理由、患者的人口统计学资料、阈值和设备的寿命。在体重为 19 公斤至 58 公斤的患者中，成功进行了 7 次无导线起搏器插入和 1 次取出。有 3 名患者通过颈内静脉植入了 Micra。1 名血小板减少症、铁幼粒细胞性贫血和 Pearson 骨髓胰腺综合征的 19 公斤基线患者在围手术期出现心包积液。小儿患者中可行无导线起搏器植入/早期取出。
